BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 11444079)

  • 1. Initiation of osteoporosis treatment after bone mineral density testing.
    Pressman A; Forsyth B; Ettinger B; Tosteson AN
    Osteoporos Int; 2001; 12(5):337-42. PubMed ID: 11444079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment of osteoporosis in women with breast cancer.
    Mincey BA; Moraghan TJ; Perez EA
    Mayo Clin Proc; 2000 Aug; 75(8):821-9. PubMed ID: 10943237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of serial bone mineral density testing for osteoporosis.
    Crandall C
    J Womens Health Gend Based Med; 2001 Nov; 10(9):887-95. PubMed ID: 11747684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of bone densitometry results on the treatment of osteoporosis.
    Fitt NS; Mitchell SL; Cranney A; Gulenchyn K; Huang M; Tugwell P
    CMAJ; 2001 Mar; 164(6):777-81. PubMed ID: 11276543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy.
    Sarkar S; Mitlak BH; Wong M; Stock JL; Black DM; Harper KD
    J Bone Miner Res; 2002 Jan; 17(1):1-10. PubMed ID: 11771654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
    Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New possibilities for diagnosis and treatment of osteoporosis.
    Miller PD
    Int J Fertil Womens Med; 2001; 46(4):215-21. PubMed ID: 11563832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis: a review and its dental implications.
    Mattson JS; Cerutis DR; Parrish LC
    Compend Contin Educ Dent; 2002 Nov; 23(11):1001-4, 1006, 1008 passim; quiz 1014. PubMed ID: 12526189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of hormone replacement therapy after diagnosis of osteoporosis by bone densitometry.
    Phillipov G; Mos E; Scinto S; Phillips PJ
    Osteoporos Int; 1997; 7(2):162-4. PubMed ID: 9166398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic prevention of osteoporotic fractures.
    Zizic TM
    Am Fam Physician; 2004 Oct; 70(7):1293-300. PubMed ID: 15508540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of osteoporosis in primary care offices.
    Gill JM; Hoffman MK
    J Womens Health (Larchmt); 2003 Jun; 12(5):473-80. PubMed ID: 12869294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group.
    Cummings SR; Palermo L; Browner W; Marcus R; Wallace R; Pearson J; Blackwell T; Eckert S; Black D
    JAMA; 2000 Mar; 283(10):1318-21. PubMed ID: 10714731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment.
    Solomon DH; Levin E; Helfgott SM
    J Rheumatol; 2000 Jun; 27(6):1496-500. PubMed ID: 10852277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
    Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for osteoporosis related to their outcome: fractures.
    van der Voort DJ; Geusens PP; Dinant GJ
    Osteoporos Int; 2001; 12(8):630-8. PubMed ID: 11580076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of combination regimens for osteoporosis--prevention and treatment.
    Miller E; Kalin MF
    Int J Fertil Womens Med; 2002; 47(5):198-204. PubMed ID: 12469706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.